178 related articles for article (PubMed ID: 33636616)
1. Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis.
Wesnes K; Myhr KM; Riise T; Kvistad SS; Torkildsen Ø; Wergeland S; Holmøy T; Midgard R; Bru A; Edland A; Eikeland R; Gosal S; Harbo HF; Kleveland G; Sørenes YS; Øksendal N; Bjørnevik K
Mult Scler Relat Disord; 2021 May; 50():102801. PubMed ID: 33636616
[TBL] [Abstract][Full Text] [Related]
2. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and body mass index in Egyptian multiple sclerosis patients.
Zamzam D; Foad M; Swelam M; AbdelHafez M; AbdelNasser A; Mahmoud R; Aref H; Zakaria M
Mult Scler Relat Disord; 2019 Feb; 28():313-316. PubMed ID: 30823981
[TBL] [Abstract][Full Text] [Related]
4. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Munger KL; Fitzgerald KC; Freedman MS; Hartung HP; Miller DH; Montalbán X; Edan G; Barkhof F; Suarez G; Radue EW; Sandbrink R; Kappos L; Pohl C; Ascherio A
Neurology; 2015 Nov; 85(19):1694-701. PubMed ID: 26453645
[TBL] [Abstract][Full Text] [Related]
5. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Brola W; Sobolewski P; Szczuchniak W; Góral A; Fudala M; Przybylski W; Opara J
Eur J Clin Nutr; 2016 Sep; 70(9):995-9. PubMed ID: 27026420
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
Muris AH; Smolders J; Rolf L; Klinkenberg LJ; van der Linden N; Meex S; Damoiseaux J; Hupperts R
PLoS One; 2016; 11(6):e0156122. PubMed ID: 27276080
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D as an early predictor of multiple sclerosis activity and progression.
Ascherio A; Munger KL; White R; Köchert K; Simon KC; Polman CH; Freedman MS; Hartung HP; Miller DH; Montalbán X; Edan G; Barkhof F; Pleimes D; Radü EW; Sandbrink R; Kappos L; Pohl C
JAMA Neurol; 2014 Mar; 71(3):306-14. PubMed ID: 24445558
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Thouvenot E; Orsini M; Daures JP; Camu W
Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
[TBL] [Abstract][Full Text] [Related]
9. The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China.
Zhang Y; Liu G; Han X; Dong H; Geng J
J Neuroimmunol; 2016 Aug; 297():127-31. PubMed ID: 27397085
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress.
Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Kallaur AP; Mezzaroba L; Lozovoy MAB; Sabino BS; Ferreira KPZ; Pereira WLCJ; Kaimen-Maciel DR; Dichi I; Reiche EMV
J Neurol Sci; 2017 Oct; 381():213-219. PubMed ID: 28991684
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
Cortese M; Munger KL; Martínez-Lapiscina EH; Barro C; Edan G; Freedman MS; Hartung HP; Montalbán X; Foley FW; Penner IK; Hemmer B; Fox EJ; Schippling S; Wicklein EM; Kappos L; Kuhle J; Ascherio A;
Neurology; 2020 May; 94(18):e1950-e1960. PubMed ID: 32300060
[TBL] [Abstract][Full Text] [Related]
12. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
Smolders J; Menheere P; Kessels A; Damoiseaux J; Hupperts R
Mult Scler; 2008 Nov; 14(9):1220-4. PubMed ID: 18653736
[TBL] [Abstract][Full Text] [Related]
13. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.
Weinstock-Guttman B; Zivadinov R; Qu J; Cookfair D; Duan X; Bang E; Bergsland N; Hussein S; Cherneva M; Willis L; Heininen-Brown M; Ramanathan M
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):189-95. PubMed ID: 21047880
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and disability in relapsing-remitting multiple sclerosis in patients with a Mexican background.
Rito Y; Flores J; Fernández-Aguilar A; Escalante-Membrillo C; Barboza MA; Amezcua L; Corona T
Acta Neurol Belg; 2018 Mar; 118(1):47-52. PubMed ID: 28975580
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
17. Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: A follow-up study.
de Carvalho Jennings Pereira WL; Flauzino T; Alfieri DF; Oliveira SR; Kallaur AP; Simão ANC; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
J Neurol Sci; 2020 Mar; 410():116630. PubMed ID: 31887671
[TBL] [Abstract][Full Text] [Related]
18. Prediction of long-term disability in Chinese patients with multiple sclerosis: A prospective cohort study.
Zhang Y; Xu Y; Xu T; Yin H; Zhu Y; Peng B; Cui L
Mult Scler Relat Disord; 2020 Nov; 46():102461. PubMed ID: 32862039
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
van der Mei IA; Ponsonby AL; Dwyer T; Blizzard L; Taylor BV; Kilpatrick T; Butzkueven H; McMichael AJ
J Neurol; 2007 May; 254(5):581-90. PubMed ID: 17426912
[TBL] [Abstract][Full Text] [Related]
20. Association of vitamin D and multiple sclerosis in India.
Pandit L; Ramagopalan SV; Malli C; D'Cunha A; Kunder R; Shetty R
Mult Scler; 2013 Oct; 19(12):1592-6. PubMed ID: 23519972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]